Amgen Inc. buy Truist Financial Co.
Start price
29.11.23
/
50%
€243.40
Target price
29.11.24
€291.23
Performance (%)
26.60%
Price
30.08.24
€301.95
Summary
This prediction is currently active. The prediction currently has a performance of 26.60%. A total of €6.20 was paid as dividends for this prediction. This prediction currently runs until 29.11.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 2.757% | 2.757% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $320.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat